Advantage Investment Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2K Hold
300
﹤0.01% 859
2019
Q2
$2K Hold
300
﹤0.01% 871
2019
Q1
$2K Hold
300
﹤0.01% 867
2018
Q4
$2K Buy
+300
New +$3.36K ﹤0.01% 915
2017
Q1
Sell
-151
Closed -$4K 1028
2016
Q4
$4K Buy
+151
New +$4.2K ﹤0.01% 781
2016
Q2
Sell
-202
Closed -$7K 902
2016
Q1
$7K Hold
202
﹤0.01% 631
2015
Q4
$6K Sell
202
-101
-33% -$3.4K ﹤0.01% 668
2015
Q3
$10K Buy
303
+101
+50% +$4.93K 0.01% 541
2015
Q2
$10K Sell
202
-7
-3% -$295 ﹤0.01% 596
2015
Q1
$9K Buy
+209
New +$7.51K 0.01% 607

Other funds holding PGEN

Advantage Investment Management's PGEN Position: Q3 2019 in Review

Advantage Investment Management held its Precigen (PGEN) position steady in Q3 2019 at 300 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

Advantage Investment Management first reported a position in PGEN in Q1 2015 and has held it in 10 quarters since. The position peaked at $10K in Q3 2015. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Advantage Investment Management held 300 shares of Precigen worth $2K as of Q3 2019.
  • Advantage Investment Management left its Precigen share count unchanged in Q3 2019.
  • Precigen made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #859 holding.
  • Advantage Investment Management first reported a position in Precigen in Q1 2015 and has held it in 10 quarters since.
  • Advantage Investment Management's Precigen position peaked at $10K in Q3 2015.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.